NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically

NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically

Despite the great advances in medicine, mortality from cardiovascular diseases keeps on growing. This tendency is not likely to change considering the pandemic proportions of obesity and diabetes. Besides, the global population is more aged as life expectancy increases, and vascular aging plays a ke...

Full description

Bibliographic Details
Main Authors: Ainara González-Moro, Inés Valencia, Licia Shamoon, Carlos Félix Sánchez-Ferrer, Concepción Peiró, Fernando de la Cuesta
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Antioxidants
Subjects:
NLRP3 inflammasome
IL-1β
IL-18
inflammaging
pharmacology
vascular
Online Access:https://www.mdpi.com/2076-3921/11/2/269

Similar Items

Similar Items